Noga Yerushalmi
Head of Israeli Bio-Incubator
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by owner
M Ventures
www.merckgroup.com
Dec 8, 2021
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million Merck
www.merckgroup.com
Jun 23, 2020
Startup from Merck Innovation Lab in Israel Markets First Predictive Maintenance Sensors Merck
en.globes.co.il
Feb 9, 2020
Merck sets up €20m fund for Israeli biotech cos
www.timesofisrael.com
Feb 18, 2019
German drugmaker Merck sets up Israel incubator to tap into chip, sensor tech
About
M Ventures is the strategic corporate venture arm of Merck KGaA of Darmstadt, Germany. M Ventures is an evergreen fund, and focuses on investing along the two investment areas Biotechnology and Technology in alignment with the strategic interests of Merck in Healthcare, Life Sciences, Electronics and Frontier Tech and Sustainability.
M Ventures is active in the Israeli ecosystem, investing in Israeli companies in the fields of interest. The fund is holding an incubator facility for housing its portfolio companies, offering both seed financing and access to dedicated laboratories within Mercks Israel-based biopharma R&D center.
M Ventures is active in the Israeli ecosystem, investing in Israeli companies in the fields of interest. The fund is holding an incubator facility for housing its portfolio companies, offering both seed financing and access to dedicated laboratories within Mercks Israel-based biopharma R&D center.
Highlights
Investment Range
Funds
0
Israeli Investments
17
Exits
0
Managed Assets
News
(4)www.merckgroup.com
Dec 8, 2021
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million Merck
www.merckgroup.com
Jun 23, 2020
Startup from Merck Innovation Lab in Israel Markets First Predictive Maintenance Sensors Merck
en.globes.co.il
Feb 9, 2020
Merck sets up €20m fund for Israeli biotech cos
www.timesofisrael.com
Feb 18, 2019
German drugmaker Merck sets up Israel incubator to tap into chip, sensor tech
The Team
(2)Robert Even
Business Development Manager, Electronics & Sustainability
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Funds
(0)Israeli Portfolio
( 11 )
Company Name
Description
Founded
Business Model
Employees
Funding Stage
Raised
ChanBio
Biopharmaceuticals for Treatment of Multiple Sclerosis
2012
B2B
1-10
Seed
undisclosed
Feelit Technologies
Nanomaterial-based Sensing Solutions for IoT Applications
2017
B2B
11-50
A
$10.43M
Immunorizon
T-and NK-cell Engagers for Cancer Therapy
2017
B2B
1-10
Acquired
undisclosed
Medisafe
Medication Management Platform
2012
B2C, B2B, B2B2C
51-200
C
$51.5M
Metabomed
Target-inhibiting Anticancer Drugs
2013
B2B
11-50
A
$30.5M
Neologic
Quasi-CMOS Computing Technology
2021
B2B
11-50
Seed
$8M
Pantheon Bioscience
Platform of Bacterial Defense Mechanism
2017
B2B
1-10
Seed
$2.15M
PillTracker
Real-time Medication Tracking Platform
2015
B2B, B2B2C
1-10
Seed
$1.22M
PxE Computational Imaging
Advanced 3D Imaging Technology
2018
B2B
1-10
Seed
$6.5M
Sentaur Biosciences
Pioneering Precision Therapeutics for Senescence Driven Diseases
2018
B2B
1-10
Seed
undisclosed
Wiliot
Battery-free Bluetooth Tags
2016
B2B
51-200
C
$269M
Investments
(17)
Date
Name
Description
Round Type
Lead Investor
Follow on
Amount
Jul 2023
Neologic
Quasi-CMOS Computing Technology
Seed
Undisclosed
Mar 2023
PxE Computational Imaging
Advanced 3D Imaging Technology
Seed
Undisclosed
Nov 2021
Neologic
Quasi-CMOS Computing Technology
Seed
Undisclosed
Jul 2021
Neologic
Quasi-CMOS Computing Technology
Pre-Seed
Undisclosed
Jul 2021
Wiliot
Battery-free Bluetooth Tags
C Round
Undisclosed
Dec 2019
Metabomed
Target-inhibiting Anticancer Drugs
Undisclosed Round
Undisclosed
Jun 2019
PxE Computational Imaging
Advanced 3D Imaging Technology
Pre-Seed
Undisclosed
Jun 2019
Pantheon Bioscience
Platform of Bacterial Defense Mechanism
Seed
Undisclosed
Jan 2019
Wiliot
Battery-free Bluetooth Tags
B Round
Undisclosed
Jun 2018
Sentaur Biosciences
Pioneering Precision Therapeutics for Senescence Driven Diseases
Seed
Undisclosed
Dec 2017
Immunorizon
T-and NK-cell Engagers for Cancer Therapy
Seed
Undisclosed
Nov 2017
Wiliot
Battery-free Bluetooth Tags
A Round
Undisclosed
Mar 2017
Medisafe
Medication Management Platform
B Round
Undisclosed
Apr 2016
Metabomed
Target-inhibiting Anticancer Drugs
A Round
Undisclosed
Nov 2013
ChanBio
Biopharmaceuticals for Treatment of Multiple Sclerosis
Seed
Undisclosed
null
Feelit Technologies
Nanomaterial-based Sensing Solutions for IoT Applications
Undisclosed
null
PillTracker
Real-time Medication Tracking Platform
Undisclosed
Media gallery
(1)Locations
Israel
Ha-Kishon St 18, Yavne, Israel
Offices Abroad
Frankfurter Str. 250, Darmstadt, Germany
Gustav Mahlerplein 102, Amsterdam, Netherlands
One Broadway, Broadway, Cambridge, MA, USA
Locations
Israel
Ha-Kishon St 18, Yavne, Israel
Offices Abroad
Frankfurter Str. 250, Darmstadt, Germany
Gustav Mahlerplein 102, Amsterdam, Netherlands
One Broadway, Broadway, Cambridge, MA, USA
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Watchlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,